🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/03/2022 | 60,46 | 62,53 | 60,46 | 61,08 | +1,02% | 3,42% | 196.848 |
| 04/03/2022 | 62,08 | 63,07 | 60,14 | 60,46 | -4,00% | 4,72% | 301.364 |
| 03/03/2022 | 64,32 | 64,70 | 62,08 | 62,98 | -1,37% | 4,08% | 230.351 |
| 02/03/2022 | 61,03 | 64,99 | 60,74 | 63,86 | +4,66% | 6,96% | 243.015 |
| 01/03/2022 | 62,67 | 63,80 | 60,38 | 61,01 | -3,38% | 5,45% | 391.773 |
| 28/02/2022 | 62,25 | 64,78 | 62,25 | 63,14 | +0,17% | 4,06% | 231.794 |
| 25/02/2022 | 64,35 | 64,52 | 62,23 | 63,04 | -2,40% | 3,55% | 308.417 |
| 24/02/2022 | 57,94 | 64,99 | 55,21 | 64,59 | +8,99% | 16,88% | 336.149 |
| 23/02/2022 | 61,76 | 62,79 | 59,16 | 59,26 | -3,48% | 5,88% | 508.472 |
| 22/02/2022 | 63,06 | 63,47 | 61,30 | 61,39 | -4,05% | 3,45% | 474.007 |
| 18/02/2022 | 68,15 | 68,15 | 61,77 | 63,98 | -8,60% | 9,37% | 736.098 |
| 17/02/2022 | 75,28 | 76,04 | 69,20 | 70,00 | -8,43% | 9,09% | 275.235 |
| 16/02/2022 | 76,30 | 77,80 | 75,04 | 76,44 | -0,92% | 3,62% | 182.582 |
| 15/02/2022 | 75,72 | 77,64 | 75,14 | 77,16 | +2,91% | 3,30% | 159.819 |
| 14/02/2022 | 75,86 | 76,79 | 74,47 | 74,97 | -0,31% | 3,07% | 167.033 |
| 11/02/2022 | 75,20 | 77,70 | 74,24 | 75,20 | +0,96% | 4,61% | 262.411 |
| 10/02/2022 | 76,24 | 80,17 | 74,07 | 74,49 | -4,59% | 8,00% | 272.350 |
| 09/02/2022 | 77,78 | 79,08 | 77,04 | 78,07 | +1,44% | 2,61% | 324.447 |
| 08/02/2022 | 77,10 | 78,30 | 75,78 | 76,96 | -0,55% | 3,27% | 115.576 |
| 07/02/2022 | 73,97 | 77,85 | 73,97 | 77,38 | +4,30% | 5,25% | 135.293 |
| 04/02/2022 | 73,94 | 75,41 | 71,60 | 74,19 | -0,42% | 5,16% | 160.460 |
| 03/02/2022 | 74,65 | 76,21 | 73,21 | 74,50 | -1,17% | 4,01% | 297.036 |
| 02/02/2022 | 76,34 | 76,53 | 74,74 | 75,39 | -1,38% | 2,34% | 220.893 |
| 01/02/2022 | 77,67 | 77,87 | 75,00 | 76,44 | -1,68% | 3,69% | 196.848 |
| 31/01/2022 | 72,17 | 78,29 | 71,78 | 77,75 | +6,75% | 9,02% | 392.414 |
| 28/01/2022 | 70,50 | 72,84 | 69,25 | 72,83 | +3,22% | 5,09% | 307.135 |
| 27/01/2022 | 71,48 | 72,35 | 70,25 | 70,56 | -0,50% | 2,94% | 315.150 |
| 26/01/2022 | 73,58 | 75,02 | 70,50 | 70,92 | -2,81% | 6,14% | 261.289 |
| 25/01/2022 | 72,18 | 76,01 | 69,96 | 72,97 | -0,61% | 8,38% | 308.738 |
| 24/01/2022 | 69,94 | 74,10 | 69,56 | 73,42 | +3,07% | 6,50% | 331.340 |